Cell & Gene Therapy for Cancer
Part of Healthcare - Oncology
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 GILD | Gilead Sciences Inc | $169.2b | $127.72 | -2.1% | 8.2M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | +0.0% | 16.1M |
 NTLA | Intellia Therapeutics, Inc | $1.4b | $13.03 | -4.4% | 27.1M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.4b | $3.42 | -0.6% | 10.3M |
 IMTX | Immatics N.V. Ordinary Shares | $1.2b | $11.33 | -0.2% | 358.3K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.7b | $3.26 | -0.9% | 2.9M |
 VOR | Vor Biopharma Inc. Common Stock | $0.6b | $14.14 | +2.4% | 1.1M |
 YDES | YD Bio Limited Ordinary Shares | $0.6b | $5.33 | -2.5% | 6.4K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.5b | $2.26 | -2.2% | 6.5M |
 IMMX | Immix Biopharma, Inc. Common Stock | $454.4m | $9.51 | -3.5% | 462.2K |
 LYEL | Lyell Immunopharma, Inc. Common Stock | $449.6m | $22.66 | +1.1% | 65.7K |
 ENGN | enGene Holdings Inc. Common Stock | $414.0m | $7.22 | -9.6% | 846.0K |
 IPSC | Century Therapeutics, Inc. Common Stock | $364.8m | $2.23 | +0.7% | 568.6K |
 TARA | Protara Therapeutics, Inc. Common Stock | $284.5m | $4.98 | -2.9% | 458.7K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $166.2m | $2.13 | 0.0% | 2.1M |
 NKTX | Nkarta, Inc. Common Stock | $142.6m | $2.83 | -3.1% | 1.3M |
 ARTV | Artiva Biotherapeutics, Inc. Common Stock | $134.7m | $10.65 | +3.2% | 133.1K |
 FATE | Fate Therapeutics, Inc. | $131.4m | $1.31 | -1.1% | 1.4M |
 ANIX | Anixa Biosciences, Inc. | $83.8m | $2.96 | -3.0% | 122.8K |
 COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $16.39 | -0.1% | 111.9K |
 ACET | Adicet Bio, Inc. Common Stock | $58.6m | $7.93 | +0.4% | 53.2K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $53.5m | $1.30 | +3.6% | 936.7K |
 INKT | MiNK Therapeutics, Inc. Common Stock | $49.4m | $10.89 | -0.5% | 14.2K |
 ESLA | Estrella Immunopharma, Inc. Common Stock | $43.9m | $1.70 | +7.6% | 43.5K |
 CELU | Celularity Inc. Class A Common Stock | $36.3m | $1.00 | -9.9% | 100.5K |
 ATRA | Atara Biotherapeutics, Inc | $35.3m | $4.99 | -0.5% | 52.3K |
 SNTI | Senti Biosciences, Inc. Common Stock | $24.0m | $1.08 | -0.5% | 142.4K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $17.4m | $6.92 | -8.3% | 24.7K |
 INAB | IN8bio, Inc. Common Stock | $13.5m | $1.57 | +4.7% | 131.1K |
 GDTC | CytoMed Therapeutics Limited Ordinary Shares | $12.1m | $0.91 | -4.3% | 4.8K |
 LNAI | Lunai Bioworks Inc. Common Stock | $10.0m | $0.31 | +0.1% | 1.9M |
 PMCB | PharmaCyte Biotech, Inc. Common Stock | $7.2m | $0.77 | +6.2% | 131.9K |
 ERNA | Ernexa Therapeutics Inc. Common Stock | $5.5m | $0.20 | +3.5% | 232.9K |
 MBIO | Mustang Bio, Inc. | $5.5m | $0.76 | +1.4% | 30.6K |
 CLDI | Calidi Biotherapeutics, Inc. | $2.3m | $0.24 | +5.2% | 2.9M |